Molina Healthcare (MOH) stock gains as Bank of America upgrades the company to Buy, citing improving Medicaid margins and earnings upside. Read more here.

BofA Securities upgrades Elevance Health and gives a rare double upgrade to Centene and Molina Healthcare.

Molina Healthcare took the "prudent" route of reaffirming its 2026 outlook as questions loom in the Medicaid business. | ...

Molina Healthcare (NYSE:MOH) has won a major new Florida Medicaid contract expected to generate about $6b in annual premiums ...

"Our full year 2026 guidance, which we reaffirm at approximately $42 billion of premium revenue and at least $5 in adjusted earnings per share" (President, CEO & Director Joseph Zubretsky). "Last ...

Investors came into second-quarter earnings for Molina concerned about how challenges in its core Medicaid business might affect the insurer. However, Molina exceeded Wall Street’s expectations for ...

Texas Medicaid is undergoing major 2026 changes, including insurer exits, policy updates, and integration of Medicare-Medicaid plans. Molina Healthcare reaffirmed its cautious outlook despite ...

Molina Healthcare Inc. shares skyrocketed more than 11% Thursday, surging to around $170.49 as investors cheered the managed ...

Molina Healthcare, Inc. (“Molina”) todayannounced the appointment of Jay Ludlam as plan president of Molina Healthcare of Missouri.

Is MOH a good stock to buy? We came across a bullish thesis on Molina Healthcare, Inc. on Dasam’s Substack. In this article, we will summarize the bulls’ thesis on MOH. Molina Healthcare, Inc.’s share ...

The insurer beat analyst expectations for adjusted earnings in the first quarter. But steeper Medicaid membership losses than ...

Molina Healthcare CEO Joe Zubretsky downplayed attempts by Republicans to gut or limit Medicaid in upcoming reconciliation bills or at the state level on a Feb. 6 fourth-quarter earnings call.